Top Story

Cirrhosis-related mortality rates increasing in U.S. since 2009

July 19, 2018

Liver cancer mortality rates increasing significantly in the U.S.

July 18, 2018
Liver cancer mortality increased from the ninth leading cause of cancer death in 2000 to sixth leading cause in 2016, according to a report published by the CDC…
FDA News

FDA grants Tecentriq-Avastin combination breakthrough therapy designation for liver cancer

July 18, 2018
The FDA granted breakthrough therapy designation to atezolizumab in combination with bevacizumab as a first-line treatment for patients with advanced metastatic…
In the Journals

Liver cancer risks, detection: 8 recent reports

July 16, 2018
Patients with liver disease such as viral hepatitis and nonalcoholic fatty liver disease with cirrhosis are at increased risk for progression to hepatocellular…
More Headlines »